The vertebrate caudal proteins, being upstream regulators of the Hox genes, play a role in establishment of the body plan. We describe analysis of two orthologous caudal genes (chick cdx-A and mouse cdx-1) by use of lacZ reporters expressed in transgenic mouse embryos. The expression patterns show many similarities to the expression of endogenous mouse cdx-1. At 8.7 days, cdx/lacZ activity within neurectoderm and mesoderm forms posterior-to-anterior gradients, and we discuss the possibility that similar gradients of cdx gene expression may function as morphogen gradients for the establishment of Hox gene expression boundaries. Our observations suggest that gradients form by decay of cdx/lacZ activity in cells that have moved anterior to the vicinity of the node. The cdx-A/lacZ expression pattern requires an intron enhancer that includes two functional control elements: a DR2-type retinoic acid response element and a Tcf/b-catenin binding motif. These motifs are structurally conserved in mouse cdx-1. q
Introduction
The mouse embryo develops in an anterior-to-posterior temporal sequence by the progressive addition of new parts to the growing posterior end. The posterior region can therefore be considered as a 'founder zone'. For paraxial and lateral plate mesoderm, the founder cells reside within the primitive streak, which terminates anteriorly at the level of the node. For neural tube, founder cells lie within the ectoderm germ layer. These migrate towards the midline to join the neural tube at its growing posterior end.
Whilst this is in progress, the Hox gene expression patterns become laid down, with the various genes acquiring their characteristic, and often unique, anterior boundaries of expression. In accordance with spatial colinearity, the order of their expression domains (anterior to posterior) corresponds with the order of the genes (3 0 -5 0 ) along their clusters (e.g. Gaunt et al., 1988) .
In recent years, the caudal (cdx) genes have become strong candidates as regulators of Hox gene expression patterns. The evidence is as follows.
(1) cdx binding motifs are present in the enhancers of several different vertebrate Hox genes (first shown by Shashikant et al. (1995) and Subramanian et al. (1995) ), and mutation of these motifs disrupts expression (Charité et al., 1998; Shashikant et al., 1995) . (2) cdx gene products have been found to stimulate Hox gene expression (Charité et al., 1998; Epstein et al., 1997; Isaacs et al., 1998; Subramanian et al., 1995) . (3) Knockout of cdx-1 results in posterior shifts of several Hox genes within mesoderm, together with accompanying homeotic mutations in the resultant vertebral structures (Subramanian et al., 1995) . Knockout of cdx-2 also results in posterior homeotic changes (Chawengsaksophak et al., 1997) .
The way in which cdx proteins might regulate Hox patterns is unclear. Two simple models have been proposed in an attempt to explain how Hox expression patterns become established. The 'timing' model (Dollé et al., 1989) , based upon the progress zone model (Summerbell et al., 1973) , proposes that Hox genes become sequentially activated, 3 0 -5 0 , within cells that remain in the founder zone, and that once cells move out of this zone their Hox expression patterns become fixed. Here, time of exposure to a Hox inducer is the important factor in setting up the patterns. In this model, the Hox inducers could be the cdx proteins since these are expressed in greatest abundance in the posterior founder zones of the embryo. Alternative 'morphogen gradient' models (e.g. Gaunt et al., 1999; Gaunt, 2000) propose that embryos contain a graded concentration of a Hox inducer, and that different Hox genes become activated at different threshold concentrations. Here, concentration of a Hox inducer is a key factor in determining pattern. In such models, the cdx proteins could be the graded morphogen, since several authors have reported that both cdx mRNAs (Gamer and Wright, 1993; Marom et al., 1997; Morales et al., 1996) and proteins (Gamer and Wright, 1993; Meyer and Gruss, 1993) are expressed in gradients along the embryo: cdx-A (in chick; cdx-1 in mouse) being most anterior, and cdx-B (cdx-4) most posterior. Two lines of evidence suggest that vertebrate cdx proteins might indeed function as morphogen gradients. The first is by analogy with Drosophila, where caudal (cad) protein forms a morphogen gradient in the syncytial blastoderm (Rivera-Pomar et al., 1995) . The cad gradient has its highest concentration at the posterior end. It sets the position of the knirps expression stripe, which is activated only within a threshold range of cad concentration. A second line of evidence lies in experiments reported by Charité et al. (1995 Charité et al. ( , 1998 . These authors showed that multimerization of the enhancer within a Hoxb-8/lacZ transgene results in a forward shift in its expression. A plausible interpretation is that multiple copies of the enhancer results in the construct becoming more sensitive to an embryonic inducer of Hox genes, and that this inducer must normally be present at higher amounts in prospective posterior cells than anterior cells. Function of the enhancer depends upon an intact cdx binding motif (Charité et al., 1998) . These observations, together with the graded expression pattern of cdx, suggest that caudal proteins may form morphogen gradients for the establishment of Hox expression boundaries. An enhancer multimerization experiment was similarly used in Drosophila to show the significance of the bicoid morphogen gradient (Struhl et al., 1989) .
In the present paper, we describe both chick cdx-A/lacZ and mouse cdx-1/lacZ reporter constructs that are graded in their expression along both neurectoderm and mesoderm of transgenic mouse embryos. Chick cdx-A is the orthologue of mouse cdx-1 (Marom et al., 1997) . The expression patterns appear to be very similar to that of endogenous mouse cdx-1 protein (Meyer and Gruss, 1993) . The initial objective was to provide clearer evidence for cdx expression gradients along the embryo. The lacZ technique, although indirect, provides a simple and highly reproducible method of detecting gene expression, uncomplicated by the background labelling that is associated with in situ hybridization or antibody staining. Our time course studies suggest that the gradient forms by a time-dependent decay of cdx activity in cells that have left the posterior founder zones of the embryo.
We note that an upstream T cell factor (Tcf)/b-catenin binding motif in mouse, responsive to Wnt signalling in cell culture assays (Lickert et al., 2000; Prinos et al., 2001) , is conserved in the chick. This upstream region taken from mouse DNA is able to generate a pattern of lacZ reporter expression that is similar to that of endogenous cdx-1 (Lickert and Kemler, 2002) . However, this upstream region taken from chick cdx-A was insufficient to generate lacZ expression in ectoderm and mesoderm of early mouse embryos, and we found it necessary to include a second enhancer located at the 5 0 end of the cdx-A first intron. The intron enhancer contains motifs, conserved between chick and mouse, for both a Tcf/b-catenin binding site and a DR2-type retinoic acid response element (RARE). Mutation of either the RARE or the Tcf/b-catenin within the cdx-A/lacZ reporter caused posterior shift in lacZ expression.
Results

cdx-A/lacZ reporter is expressed in gradients in transgenic embryos
The principal cdx-A/lacZ reporter construct that we used in order to obtain a cdx-like pattern of lacZ expression (construct 1, Fig. 1B ; Figs. 2 and 5) includes 1.4 kb of cdx-A upstream sequence, the first exon, the first 2.1 kb of the first intron, and the first part of the homeobox in exon 2. A second construct (construct 2; Fig. 1C ) resembles construct 1 but includes an additional 4.3 kb of sequence from the cdx-A first intron. Construct 2 was expressed with an apparently identical pattern to construct 1 (not shown).
All studies on transient transgenic embryos, and the initial studies upon transgenic lines, were made at 8.5-8.7 days of gestation. At this time, endogenous mouse cdx-1 expression is known to be located within a broad, posterior domain of both neurectoderm and mesoderm (e.g. Meyer and Gruss, 1993) . The staining seen initially in two transient transgenics was apparently confined entirely to the neural tube, and was graded over the region adjacent to the level of the first few somites ( Fig. 2A, A 0 ). Five lacZ-expressing transgenic lines were then produced. Two of these displayed very strong staining that was seen in both neural tube and paraxial mesoderm (Fig. 2B) . The staining formed a clear gradient over somites posterior to, and including, somite 5 (Fig. 2B, B 0 ). The staining in the mesoderm was considerably weaker than that in the neural tube. When strongly expressing lines were stained only briefly (40 min) graded expression was evident over the neural tube posterior to the level of somite 1 (Figs. 2C, C 0 and 5H). Three transgenic lines produced much weaker staining that was detected only within neural tube at 8.5 days (not shown, but like Fig. 2A ). This difference between transgenic lines appeared to be quantitative rather than qualitative, since even weakly expressing lines showed expression within mesoderm at early stages of development (not shown, but like Fig. 5A , B).
2.2. cdx-A/lacZ reporters require an intron element for cdxlike expression in transgenic embryos
As a first step towards locating the cdx-A enhancer element within constructs 1 and 2, we prepared a new construct (construct 3; Fig. 1D ) which contains the same upstream non-coding region as construct 1, but only part of the first exon, and non of the cdx-A intron. The intron used instead in construct 3 was the second intron from human b-globin. Four transgenic embryos were generated. One of these expressed lacZ, but expression was confined to a few cells in the posterior embryo (Fig. 3A) . Sections showed that these were located in the hindgut, and that no labelled cells were present within neurectoderm or mesoderm (Fig. 3A  0 ). An additional construct, construct 4 ( Fig. 1E ), resembles construct 3 but includes an additional 6 kb of cdx-A upstream sequence. Of eight independent transgenic embryos produced with this construct, non expressed lacZ (not shown).
Taken together, the findings from constructs 1 to 4 indicate the importance of regulatory elements at the 5 0 end of the cdx-A first intron. Upstream sequence alone, when taken from chick, provided little evidence of enhancer activity in transgenic mouse embryos. This finding differs . Constructs 5 and 6 resemble construct 1 except that the RARE and Tcf/b-catenin motifs within the intron enhancer have been mutated, respectively. (F,G) show, respectively, the number of nucleotides in the RARE and Tcf/b-catenin motifs (underlined; Fig. 4 legend) that match the consensus sequence both before (upper) and after (lower) mutation. R, Eco R1; B, Bam H1; H, HindIII; X, Xho1; C, Cla1; K, Kpn1; S, Sal1; N, Not1. from the recent finding for mouse cdx-1/lacZ constructs, where an apparently similar early pattern of expression, up to 9.5 days, required only the 700 bp of sequence upstream of the coding region (Lickert and Kemler, 2002) .
Conserved Tcf/b-catenin binding sites and a RARE within the cdx-A reporter construct
We sequenced the 4 kb cdx-A gene component of the reporter construct 1, and have submitted this to the EMBL database (accession no. AJ534305). When this is compared, over non-coding regions, with mouse cdx-1 (Hu et al., 1993) only two substantial regions of conservation are found (Fig. 4A, B ). Both contain conserved transcription factor binding sites and are therefore putative enhancer elements. The positions of these are indicated by white boxes in Fig. 1 .
One conserved element is located upstream of the coding region ( Fig. 4A ). This includes both a modified TATA box and a single Tcf/b-catenin binding site. A further potential Tcf/b-catenin binding motif (not shown) is located 1119 bp upstream of the coding region. The activity of upstream Tcf/b-catenin binding elements has been characterized for mouse cdx-1 using luciferase assays in cultured cells (Lickert et al., 2000; Prinos et al., 2001) . Houle et al. (2000) reported a highly modified RARE upstream of mouse cdx-1. However, we did not find any obvious conservation of this motif in chick DNA (not shown).
The second conserved element is located within the intron (Fig. 4B ). We found that this includes complementary sequences to both a Tcf/b-catenin binding site and a DR2-type RARE. Since we observed a cdx-like pattern of lacZ expression only in constructs that contain intron sequences, we considered that this is likely to be an essential element in our reporter construct. It is already known that mouse cdx-1 is stimulated by both Wnt proteins, which use Tcf/b-catenin as a second messenger (Lickert et al., 2000; Prinos et al., 2001) , and by retinoic acid (Houle et al., 2000; Prinos et al., 2001) .
To test the role of the intron RARE, we produced a new construct (construct 5; Fig. 1F ) in which the RARE of construct 1 is mutated to disrupt all of the consensus sequence ( Fig. 1F ; Chambon, 1994; legend to Fig. 4) . Of six 8.7-day transient transgenic embryos generated with construct 5, three were seen to express lacZ. In each of these, expression was detected only in the neural tube (Fig. 3B, C) , and in comparison to the expression of construct 1 (e.g. Fig. 2A -C), was confined mainly to posterior parts. Thus, while construct 1 is expressed in neural tube up to the level of somite 1, construct 5 is expressed mainly posterior to the level of somite 7.
To test the role of the intron Tcf/b-catenin binding motif, we produced construct 6 (Fig. 1G ) in which this site is mutated to destroy the consensus sequence (Lickert et al., 2000; legend to Fig. 4 ). Construct 6 is otherwise identical to construct 1. Of three transient transgenic 8.7-day embryos produced with construct 6, two expressed lacZ (Fig. 3D ). In both, staining was confined to a minority of cells in the posterior neurectoderm. No labelled cells were seen anterior to the level of somite 13, or in the mesoderm.
These findings demonstrate functional roles for both the RARE and the Tcf/b-catenin binding motif in the conserved intron enhancer of chick cdx-A. Since both motifs are Fig. 4 . Sequence homologies between chick cdx-A (upper sequence) and mouse cdx-1 (lower sequence) in their non-coding regions. Nucleotide 1 is taken in both species to be the first nucleotide of the coding region. (A) The region of conserved upstream sequence that corresponds with the enhancer element characterized for mouse cdx-1 by Lickert et al. (2000) and Prinos et al. (2001) . This includes a conserved Tcf/b-catenin binding motif and the presumed TATA element (Hu et al., 1993) . Both are shown boxed. The Tcf/b-catenin box is underlined by a striped bar. Tcf (with b-catenin as coactivator) binds to the consensus sequence CTTTGA/TA/T (Lickert et al., 2000 , and references therein). (B) The region of conserved intron sequence. This includes complementary sequences (shown boxed) to a DR2-type RARE and a Tcf/b-catenin binding motif. A RARE normally consists of direct repeats of the consensus sequence PuGG/TTCA spaced by either two (DR2) or five (DR5) nucleotides (Chambon, 1994) . The RARE repeats are shown underlined by grey bars. Chick and mouse sequences were compared and aligned using bestfit from the GCG analysis package (set to gap weight 45 and length weight 2). (A) shows the result from comparing the 1130 bp immediately upstream of the coding regions. (B) shows the result from comparing the first 1759 bp of the intron sequences.
conserved in the mouse, it seems likely that they play a similar role in this species.
Formation of the gradients detected by chick cdx-A/lacZ expression
Since the range of Hox genes activated in any cell may depend upon the dosage of cdx (e.g. Charité et al., 1998) , we considered that the cdx gradient might be responsible for the establishment of Hox expression patterns along the embryo, and we attempted to elucidate how the gradient becomes formed.
During vertebrate development, newly organized neurectoderm and mesoderm tissues emerge from posterior founder regions. These are apparently the same regions as those that show high levels of cdx-A/lacZ activity (Fig. 5) . Two simple mechanisms could establish the cdx gradient along the embryo. First, there may be a progressive increase in the concentration of cdx in both the posterior region and the newly emergent cells, thereby generating a concentration gradient along the embryo. Second, there may be a constant concentration of cdx in posterior parts, but cells that emerge from here may be less stimulated to express cdx, and so a gradient might be formed by progressive decay in cdx activity levels. To distinguish between these alternatives, it seemed important to test whether or not the cdx concentration displays a time-dependent increase over the period of gastrulation, from 7.5 to 9 days. To permit comparison of expression levels at different embryo stages, all the embryos tested in this section (Fig. 5) were from the same (high expressing) transgenic line, and all embryos were stained for 40 min under identical conditions. cdx-A/lacZ expression commenced at 7.5 days in the posterior tissues of the embryo (Fig. 5A, B) . The expression apparently reached high levels rapidly since embryos were seen to be either unstained (before 7.5 days) or strongly stained (after 7.5 days). Sectioning showed that neurectodermal staining is stronger than that in primitive streak or mesoderm, and there is a slight reduction in the intensity of staining towards the anterior boundaries within both neurectoderm and mesoderm (Fig. 5B) . The anterior boundary in mesoderm is more posterior than that in neurectoderm. The endoderm is also labelled at this time, with an anterior boundary similar to that in mesoderm (Fig. 5B ). These observations are apparently the same as those obtained for endogenous mouse cdx-1, as detected both by in situ hybridization and by antibody staining of protein (Meyer and Gruss, 1993; Ikeya and Takada, 2001) .
Over the following 1.5 days (Fig. 5A -I ), the lacZexpressing tissues elongate as new neural and mesoderm tissue leaves the posterior founder zones. The neural plate begins to roll up at 8.25 days to reveal, below, an apparent gradient in lacZ staining within the underlying mesoderm (Fig. 5E ). Over the period 7.5 -8.25 days (Fig. 5A -F) , there is no detectable increase in the maximal levels of cdx-A/lacZ activity, and indeed, levels become reduced over the period 8.25 -9 days (Fig. 5E -I ). This reduction is apparently more rapid in mesoderm than in neurectoderm. Graded expression in these layers does not therefore arise by progressive increase in the cdx-A/lacZ activity within the posterior founder tissues. We therefore suggest that the gradients, which become apparent in neurectoderm and mesoderm over the period 8.25 -8.7 days (Fig. 5E -H) , are more likely due to a time-dependent decay of cdx-A/lacZ (and cdx-1) activity in cells that have left the posterior founder zone. This conclusion is supported by the observation that at 8 days, there is little evidence of graded expression along either neurectoderm or mesoderm, and lacZ expression remains strong even in anteriormost parts of the expression domains (Fig. 5D) . By 8.5 -8.7 days, however, anteriormost expression has weakened relative to posterior expression, thereby generating the gradients (cf. Fig. 5D with Figs. 2A -C and 5H ). As the domain of cdx-A/lacZ activity in neural tube decays and recedes along the embryo, it is seen that activity tends, over the period 8.7 -9 days (Fig. 5H, I ), to remain as a more persistent domain within the region adjacent to somites 3-5.
2.5. Formation of the gradients detected by expression of a mouse cdx-1/lacZ transgene To test whether a mouse cdx-1/lacZ transgene establishes an expression gradient in a similar way, we prepared a construct that utilizes mouse cdx-1 upstream and intron gene sequences (construct 7; Fig. 1H ). Two independent lines of transgenic mice gave similar patterns of expression for construct 7, and the most strongly expressing line is shown in Fig. 6 .
Many important aspects of construct 7 (mouse DNA) expression are similar to those of construct 1 (chick DNA). Thus, expression commences at the same time (not shown), and with the same distribution ( Fig. 6A -C) . Expression at 8 days is ungraded along both mesoderm (Fig. 6B) and neurectoderm ( Fig. 6C ), but it becomes graded along these tissues by 8.7 days (Fig. 6D, E) . The anterior boundaries are at the level of somite 1 in neurectoderm and somite 5 in somitic mesoderm (Fig. 6B, D) . To establish that the observed gradients in neural tube and somites are not a consequence of lacZ activity in underlying tissues, serial transverse sections were examined (Fig. 6F -M) . These show graded lacZ activity within neural tube and somites ( Fig. 6F-K) , and also lateral plate mesoderm (Fig. 6H -K) .
The results provide further evidence that the gradients arise by time-dependent decay of cdx/lacZ activity as cells move away from the vicinity of the node. Thus, somite 5 at 8 days is labelled as strongly as more posterior parts of the paraxial mesoderm (Fig. 6B ), yet somite 5 at 8.7 days is only weakly labelled (Fig. 6D) .
A notable difference between chick and mouse constructs is that chick cdx-A/lacZ activity in somites declines more rapidly than does mouse cdx-1/lacZ activity. Thus, although the ratio of somite to neural staining intensity is similar for both constructs at 8 days (Figs. 5D and 6B), this ratio at 8.7 days is greatly reduced for cdx-A/lacZ activity (Figs. 2C and 5H), though not for cdx-1/lacZ (Fig. 6D) . Somite expression of cdx-A/lacZ at 8.7 days is detected only after prolonged staining (Fig. 2B ).
2.6. cdx-A/lacZ and cdx-1/lacZ activity in 9 -10.5 day embryos By 9 days, rhombomeres have become distinct within the hindbrain, permitting localization of the anterior boundary of cdx-A/lacZ activity to the level of the junction between rhombomeres 7 and 8 (Fig. 7A ). Many authors (e.g. Lumsden, 1990 ) regard this position as lying within the hindbrain, with the junction between the hindbrain and spinal cord lying adjacent to the junction of the last occipital and first cervical somites (that is, somites 4 and 5; large arrow in Fig. 7A ). The anterior boundary of cdx-1/lacZ expression is similar to that of cdx-A/lacZ activity (level of somite 1; Fig. 7D ), but cdx-1/lacZ activity appears to decay more rapidly in anterior neural tissue.
By 9 days, both mouse ( Fig. 7D) and chick (not shown) constructs become down-regulated in paraxial mesoderm posterior to somite 11, but a gradient of activity persists over those somites (5 -11) that are destined to form the cervical vertebrae (Fig. 6E) . By 9.5 days, lacZ activity in somites has become confined to the dermamyotome (Fig. 7E 0 ).
The forelimb bud at 9.5 days shows widespread labelling within both mesoderm and the apical ectodermal ridge (AER) (Fig. 7B for chick and Fig. 7E , E 0 for mouse constructs). By 10.5 days (Fig. 7C , C 0 , F, F 0 ) forelimb expression becomes more focussed within the AER. Occasional labelled cells are also detected in dorsal, but not ventral, forelimb bud ectoderm (Fig. 7C  0 ) . Weaker expression at this stage is seen in the AER of the hindlimb bud and within the tailbud (Fig. 7C, F) . At 9 days, lacZ-expressing cells are seen to be streaming laterally from the neural tube (Fig. 7A, A  0 ). These cells are apparently the same as those detected earlier using the anti-cdx-1 antibody (Meyer and Gruss, 1993) . We believe that they are neural crest cells, since later, by 9.5 days, they are organizing to form the cervical trunks and the spinal ganglia (Fig. 7B , E, E 0 ). As already noted for somite expression, expression in these neural structures persists longer for the mouse construct than the chick (Fig. 7C, F) .
cdx-1 and cdx-1/lacZ expression compared by in situ hybridization
Nearby sections of cdx-1/lacZ transgenic embryos were hybridized either to a probe for detection of endogenous cdx-1 mRNA (not reactive with transgene), or else to a probe for detection of lacZ mRNA (transgene). At 8 days (Fig. 8A -C) , cdx-1 and lacZ mRNAs are expressed with the same anterior boundaries, both within mesoderm and neurectoderm, along the P-A axis. These boundaries are apparently the same as those for cdx/lacZ staining (Figs. 5D and 6B, C). However, unlike the results obtained for lacZ protein activity at 8 days (Figs. 5D and 6C) , the anterior regions of mRNA expression are, most notably in neurectoderm, less intense than more posterior regions. In terms of the time-dependent decay model considered above, this suggests that the lacZ (and cdx-1) mRNA may decay more rapidly than the lacZ protein.
At 8.7 days, cdx-1 and lacZ mRNAs are considerably less abundant than at 8 days. Fig. 8D -F shows the maximal levels of expression detected along the embryo. Both transcript types are similarly distributed within neural tube, somites and lateral plate mesoderm, and in an overall pattern like that shown by lacZ protein activity (e.g. Fig. 6J ). By 9.5 days, expression of cdx-1 and lacZ mRNAs was not detected significantly above background (not shown). LacZ staining activity was therefore detected over a duration much longer than that over which cdx-1 or lacZ mRNAs could be detected by in situ hybridization.
Discussion
Gradients of cdx-A/lacZ and cdx-1/lacZ expression
The initial objective in this study was to seek evidence for cdx gene expression gradients by use of cdx/lacZ reporters. Gradients of cdx expression have been described before by use of both in situ hybridization and protein staining (e.g. Gamer and Wright, 1993; Marom et al., 1997; Meyer and Gruss, 1993; Morales et al., 1996) , but these gradients have typically not been entirely clear, nor have they been especially noted, for cdx-1, over those tissues that are known to show homeotic mutations in cdx-1 knockout mice (i.e. tissues that give rise to the cervical and anterior thoracic vertebrae; Subramanian et al., 1995) . In the present study, we show that cdx-A/lacZ and cdx-1/lacZ reporters are expressed, in 8.5 -9 day embryos, in clear-cut gradients over those somites (5 -11; Fig. 2 of Gaunt et al., 1999) that give rise to the cervical vertebrae. We suggest that this finding, together with reports that Hox expression boundaries respond to cdx activation in a dose-dependent way (Charité et al., 1998, for Hoxb-8; Epstein et al., 1997, for Hoxc-6 and b-9) , are consistent with a cdx-1 morphogen gradient for the patterning of the anterior vertebral column. We adopt here the definition of Wolpert et al. (1998) that 'a morphogen is any substance active in pattern formation whose spatial concentration varies and to which cells respond differently at different threshold concentrations'.
We provide evidence that gradients of cdx/lacZ expression in the ectoderm and mesoderm germ layers form, at least in part, by progressive decay in activity as cells move away from the vicinity of the primitive streak. The exact position along the embryo where this decay begins is not certain from our data. Progressive decay in cdx activity within cells that have left the posterior region of the embryo could provide part of the mechanism whereby the organizer region regulates A -P patterning along the body axis. This progressive decay in cdx activity might account for the appearance of progressive posterior shifts in cdx expression boundaries along the embryo (Pillemer et al., 1998) . We provide evidence that decay in mRNA (of both endogenous cdx-1 and the lacZ transgene) within cells leaving the posterior embryo occurs more rapidly than does decay in cdx/lacZ protein activity. If cdx-1 protein similarly decays more slowly than cdx-1 mRNA, then this could explain why in situ hybridization studies (e.g. Prinos et al., 2001 ) typically show anterior boundaries of expression that are more posterior than those noted in a protein localization study (Meyer and Gruss, 1993) .
Reporter studies are open to the criticism that the tissuespecific pattern of expression may not be truly representative of that of the endogenous gene. Against this criticism, however, we found that both lacZ mRNA and endogenous cdx-1 mRNA are expressed in similar patterns in 8-and 8.7-day cdx-1/lacZ transgenic embryos. In addition, we obtained similar expression of cdx/lacZ reporters prepared from both mouse cdx-1 and its chick orthologue, cdx-A. A further criticism of the use of lacZ reporter constructs is that we cannot be sure that rates of decay in expression are the same as for the products of the endogenous cdx-1 gene. Thus, we cannot be sure that the slopes of the lacZ activity gradients precisely mimic endogenous cdx-1 gradients. However, the anterior limits of both gradients are similar since we found that both cdx-1/lacZ and endogenous cdx-1 mRNAs share the same anterior boundary in the 8-day embryo.
We consider that our findings are less predicted by a timing model for the setting of Hox expression boundaries (see Section 1). In terms of the timing model (Dollé et al., 1989) , the cdx-1 gradient is probably of no functional significance. In this model, it is while cells remain in the posterior part of the embryo, where cdx levels are high, that Hox genes become activated in a temporally regulated way. This temporal regulation then generates the characteristic patterns of Hox expression in cells as they move anterior to the node.
In both timing and morphogen gradient models, the Hox expression domains, once established, become committed to cellular memory by binding of Polycomb group proteins (e.g. Akasaka et al., 2001) . Even in the morphogen gradient model, timing must be crucial. Levels of cdx protein in each cell are progressively falling, and the memory mechanism must be invoked when cells are in an appropriate stage of Hox gene activation.
Although cdx proteins may help determine the anterior boundaries of Hox gene expression, it is unlikely that they are responsible for the full activation of Hox genes within their domains. Thus, for example, we note that Hoxa-7/lacZ expression (Gaunt, 2001) continues to rise in regions of the neural tube where cdx-1 activity is falling. This up-regulation, which is in part responsible for forward spreading (Gaunt, 2001) , indicates the existence of additional Hox-activating factors. These could include cdx-2 and -4, but the up-regulation could also be attributable to, for example, auto-and cross-regulation by other Hox proteins (e.g. Gould et al., 1997; Hooiveld et al., 1999) .
3.2. The enhancer elements in chick cdx-A and mouse cdx-1 Lickert and Kemler (2002) have recently described lacZ reporter studies upon mouse cdx-1. They found that upstream sequence alone is able to induce a pattern of lacZ activity in transgenic embryos that resembles endogenous cdx-1 expression. Essential elements in their enhancer were Tcf/b-catenin binding sites and a variant RARE.
In contrast, we found that upstream sequence alone from chick cdx-A was not able to induce this lacZ activity pattern in transgenic mouse embryos, but the pattern was generated when reporter constructs included the 5 0 end of the cdx-A first intron. This region of the intron includes a DR2-type RARE and a nearby Tcf/b-catenin binding motif. Mutation of either of these sites resulted in posterior shift in the anterior boundary of lacZ activity, as detected at 8.7 days. These intron enhancer motifs are structurally conserved in mouse cdx-1, and so we expect that they are similarly functional in this species. It is possible that the upstream and intron enhancers have overlapping and additive functions, and both may be required for appropriate establishment of the cdx concentration gradient. Our failure to find substantial enhancer activity upstream of chick cdx-A may be a problem associated with the analysis of chick sequences in mouse. An alternative possibility is that the upstream enhancer is less active in chick. In keeping with this, we were unable to detect a motif in chick DNA that is structurally conserved with the upstream RARE of mouse (Houle et al., 2000; Lickert and Kemler, 2002) .
Upstream regulators of the cdx genes
From the above, and other recent studies (e.g. Ikeya and Takada, 2001; Lickert et al., 2000; Prinos et al., 2001; Allan et al., 2001) , two substances are implicated as the upstream regulators of cdx-1
Retinoic acid is one. This is synthesized by the postimplantation mouse embryo as an essential developmental hormone, whose lack leads to early embryonic abnormalities and death (Niederreither et al., 1999) . A lacZ reporter construct regulated by only a RARE and an inducible heat shock promoter produced a pattern of expression with some similarities to that now shown for cdx-A/lacZ and cdx-1/lacZ (Rossant et al., 1991) . In particular, expression commenced rapidly at 7.5 days, with a sharp anterior boundary in the hindbrain. However, unlike cdx-A/lacZ and cdx-1/lacZ there were no gradients in expression, and similar anterior boundaries were detected in both ectoderm and mesoderm.
The second regulator of cdx-1 is Tcf/b-catenin activity, which is, in turn, known to be stimulated by several different Wnt proteins. Of these, Wnt-3a is a strong candidate for the regulation of cdx-1 in the early embryo. The following lines of evidence point to this, and to a gradient of Wnt/Tcf/bcatenin signalling along the embryo. (1) The expression pattern of Wnt-3a (Takada et al., 1994; Bouillet et al., 1996) resembles that of the most intense cdx-A/lacZ and cdx-1/ lacZ activities, and Wnt-3a protein is known to activate cdx-1 expression in cultured cells (Lickert et al., 2000; Prinos et al., 2001) . (2) Wnt-3a 2/2 mice show reduced expression of cdx-1, and homeotic mutations similar to those seen in cdx-1 2/2 mice (Ikeya and Takada, 2001) . (3) Increasing severity in Wnt-3a deficiency results in increasing severity in homeotic mutations (Greco et al., 1996) . (4) Posterior-to-anterior gradients in Tcf/b-catenin activity have been observed along the Xenopus neural plate (Kiecker and Niehrs, 2001) .
The means by which the Wnt/Tcf/b-catenin activity gradient is generated is unclear. One possibility is decay in Wnt/b-catenin components once cells have left the posterior region of the embryo. A second possibility that concentration gradients of Wnt proteins might be established by long-range diffusion (Kiecker and Niehrs, 2001 ) seems unlikely to be operable over the length of the 8.5 -9 day spinal cord. Overall, however, it remains possible that the gradients of cdx-A/lacZ and cdx-1/lacZ activity now reported might depend, at least in part, upon an underlying gradient of Wnt/Tcf/b-catenin activity.
Experimental procedures
4.1. Preparation of chick cdx-A/lacZ and mouse cdx-1/lacZ reporter constructs
The chick cdx-A gene was cloned from a genomic cosmid library (Stratagene), and restriction enzyme maps were prepared over the region of the gene ( Fig. 1A ; see also Frumkin et al., 1991) .
To make construct 1 (Fig. 1B) , the splice acceptor site at the 3 0 end of cdx-A intron 1 was cloned by PCR as a 194 bp fragment (88 bp of intron, and 106 bp of exon 2). The PCR fragment incorporated HindIII and Bam HI sites at the 5 0 and 3 0 ends, respectively, and was subcloned into Bluescript KS 2 . Downstream of this insert, lacZ/SV40 poly A (Gaunt et al., 1999) was added as a Bam HI fragment. Upstream of the insert, the HindIII/Cla I fragment of chick cdx-A was inserted into the Bluescript polylinker. Construct 2 (Fig. 1C) was made as for construct 1, but by inserting, instead, the 9.6 kb HindIII fragment of cdx-A into the Bluescript polylinker.
To make construct 3 (Fig. 1D) , the second intron of the human b-globin gene, including splice sites and adjacent regions of the second and third exons (11 nucleotides of b-globin exon 2 and 20 nucleotides of exon 3), was cloned as an 850 bp PCR fragment. This intron has been used previously in the preparation of reporter constructs from unrelated genes, since it does not, apparently, contain endogenous control elements (Martensson et al., 1997) . The PCR fragment incorporated Eco RI and Bam HI sites at its 5 0 and 3 0 ends, respectively, and was subcloned into Bluescript KS 2 . Downstream of this insert, lacZ/SV40 poly A was inserted as a Bam HI fragment. An Eco RI site was introduced by in vitro mutagenesis into chick cdx-A exon 1 (after nucleotide 390). DNA extending 1.8 kb upstream of this Eco RI site, to the position of the HindIII site, was inserted into the HindIII/Eco RI sites of the Bluescript polylinker. Sequencing reactions confirmed that cdx-A exon 1 was in the same reading frame as b-globin exon 2, and that b-globin exon 3 was in frame with lacZ.
In construct 4 (Fig. 1E) , the region of upstream sequence present in construct 3 was extended from 1.5 to 7.5 kb. For this, the 6 kb Xho I/HindIII fragment of cdx-A (Fig. 1A) was inserted into the Xho I/HindIII sites of the Bluescript polylinker in construct 3.
Construct 5 is identical to construct 1 (Fig. 1B) , except that a RARE motif located within the intron is mutated as shown (Fig. 1F) . The RARE is located just upstream of a Pst I site, and the mutation was introduced by a PCR reaction upon the 600 bp Bam HI/Pst I intron fragment (Fig. 1A) . The mutated Bam HI/Pst I fragment was then used to replace the corresponding normal fragment of construct 1. To facilitate this step, the mutation contains a diagnostic Xho I site.
Construct 6 resembles construct 1, except that a Tcf/bcatenin binding motif located within the intron is mutated as shown in Fig. 1G . The site is located just downstream of a Pst I site. The mutation was introduced by PCR upon the 1 kb Pst I/Eco RI intron fragment (Fig. 1A) , and then this mutated fragment was used to replace the corresponding normal fragment of construct 1. The mutation contains a diagnostic Spe I site.
All above constructs were isolated from the Bluescript vector using Sal I plus Xba I, followed by agarose gel electrophoresis. Construct 2 was cut from the gel after only partial digestion with Sal1.
Construct 7 (Fig. 1H ) was made as for construct 1 except that, instead of chick cdx-A DNA, a 5.7 kb Kpn I/HindIII fragment of the mouse cdx-1 gene was inserted into the Bluescript polylinker. The mouse cdx-1 DNA was isolated from a 129 strain genomic Lambda library (Kaestner et al., 1994) . Since this clone did not include the splice acceptor site, construct 7 contains this site from chick cdx-A. Apart from the splice site itself, no obvious homology was found between the adjacent 80 bp of chick intron sequence, and the corresponding region in mouse (not shown). The construct was isolated from vector using Kpn I plus Spe I, followed by gel electrophoresis.
Transgenic embryo production and staining
DNA constructs were, after separation from plasmid DNA, electroeluted from agarose/TBE gels, purified by phenol -chloroform extraction, and used to prepare transgenic embryos as described by Gordon (1993) .
Transgenic animals were identified by Southern blots of Bam H1 cut genomic DNA, hybridized to a 32 P-lacZ probe. In the case of transient transgenic embryos, genomic DNA was prepared from the whole embryos after first noting absence of staining for lacZ activity.
Embryos were taken to be at 0.5 days of development at midday on the day of the copulation plug. X-gal staining of embryos, to detect lacZ activity, was as described by Hogan et al. (1994) , followed by fixation in 4% formaldehyde. For sectioning, stained embryos were dehydrated, embedded in paraffin wax, sectioned at 14 mM and then counterstained in 0.5% neutral red for 10 s.
In situ hybridization
Hybridization of 35 S-labelled riboprobes to sections of cdx-1/lacZ transgenic embryos was carried out as described by Gaunt (1987) . The cdx-1 probe, prepared from a cDNA template, comprised 250 bp downstream of nucleotide 94 in the homeobox. This probe did not, therefore, contain any of the cdx-1 sequence contained within the transgene. The lacZ probe was as described earlier (Gaunt, 2001 ).
